+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathology"

Neurological Biomarkers Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neurological Biomarkers Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
Neurology Secrets. Edition No. 7 - Product Thumbnail Image

Neurology Secrets. Edition No. 7

  • Book
  • August 2025
Osborn's Brain. Edition No. 3 - Product Thumbnail Image

Osborn's Brain. Edition No. 3

  • Book
  • November 2023
Diagnostic Pathology: Neuropathology. Edition No. 3 - Product Thumbnail Image

Diagnostic Pathology: Neuropathology. Edition No. 3

  • Book
  • January 2022
  • 900 Pages
Loading Indicator

The Neuropathology market is a subset of the Neurosciences field that focuses on the diagnosis and treatment of diseases of the nervous system. It involves the study of the structure and function of the brain, spinal cord, and peripheral nerves, as well as the diagnosis and treatment of neurological disorders. Neuropathology is a rapidly growing field, with advances in technology and research leading to new treatments and therapies. Neuropathology is a highly specialized field, requiring extensive training and experience. It is often used in conjunction with other medical disciplines, such as neurology, psychiatry, and neurosurgery. Neuropathologists are involved in the diagnosis and treatment of a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke. Companies in the Neuropathology market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more